Committee for Advanced Therapies (CAT) meeting with interested parties

• Date:
  Thursday, 11 December 2014, All day
• Location:
  European Medicines Agency, Amsterdam, the Netherlands

CAT engages in active dialogue with its interested parties on a regular basis. During its December 2014 annual meeting CAT and its interested parties discussed the following scientific topics: the revision of the CAT reflection paper on classification with a special emphasis on CAT's current considerations on 'substantial manipulation' and 'non-homologous use'; the application of the concept of risk-based approach during the development and marketing authorisation of advance-therapy-medical products (ATMPs); the CAT work plan for 2015-2016 and other procedures and support to ATMP developers. Other issues and questions from the participating interested parties were also addressed. Registration by invitation only.

Documents

Agenda - Committee for Advanced Therapies (CAT) meeting with interested parties

Reference Number: EMA/CAT/750592/2014

Report of the Committee for Advanced Therapies (CAT) meeting with interested parties

Reference Number: EMA/CAT/23438/2015

Presentation - ATMPs classification (Belaà¯d Sekkali)

Presentation - CAT’s views on classification of ATMPs: homologous use (Nicolas Ferry)

Presentation - The risk-based approach for ATMP (Egbert Flory)

Presentation - CAT workplan 2015-2016 (Patrick Celis)